Cisen Pharmaceutical Co Ltd
Cisen Pharmaceutical Co., Ltd., together with its subsidiaries, research, develops, produces, and sells drug products in China and internationally. The company's chemical preparations include basic infusion, therapeutic infusion, liver disease medication, nervous system drugs, anti-tumor and adjuvant drugs, nutritional infusion, contrast agents, cardiovascular and cerebrovascular drugs, anti-infe… Read more
Cisen Pharmaceutical Co Ltd (603367) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.050x
Based on the latest financial reports, Cisen Pharmaceutical Co Ltd (603367) has a cash flow conversion efficiency ratio of 0.050x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥311.93 Million) by net assets (CN¥6.19 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cisen Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Cisen Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Cisen Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cisen Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Topdanmark AS
PINK:TPDKY
|
-0.107x |
|
Hanwang Technology Co Ltd
SHE:002362
|
-0.036x |
|
Drägerwerk AG & Co. KGaA
PINK:DGWPF
|
0.050x |
|
Zhejiang Unifull Industrial Fibre Co Ltd
SHE:002427
|
0.052x |
|
MORIMATSU INT.H.C. (HK)
F:1S5
|
N/A |
|
NORMA Group SE
OTCGREY:NOEJF
|
0.037x |
|
Gujarat Pipavav Port Limited
NSE:GPPL
|
0.085x |
|
Xiandai Investment Co Ltd
SHE:000900
|
0.047x |
Annual Cash Flow Conversion Efficiency for Cisen Pharmaceutical Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Cisen Pharmaceutical Co Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥5.99 Billion | CN¥570.85 Million | 0.095x | +21.85% |
| 2023-12-31 | CN¥5.77 Billion | CN¥451.24 Million | 0.078x | +62.23% |
| 2022-12-31 | CN¥5.36 Billion | CN¥258.35 Million | 0.048x | +4.39% |
| 2021-12-31 | CN¥5.06 Billion | CN¥233.60 Million | 0.046x | -48.52% |
| 2020-12-31 | CN¥4.80 Billion | CN¥431.01 Million | 0.090x | +126.48% |
| 2019-12-31 | CN¥4.57 Billion | CN¥181.26 Million | 0.040x | -59.51% |
| 2018-12-31 | CN¥4.15 Billion | CN¥406.68 Million | 0.098x | -17.08% |
| 2017-12-31 | CN¥3.72 Billion | CN¥439.61 Million | 0.118x | -7.08% |
| 2016-12-31 | CN¥2.30 Billion | CN¥291.97 Million | 0.127x | +0.13% |
| 2015-12-31 | CN¥2.10 Billion | CN¥266.24 Million | 0.127x | +775.81% |
| 2014-12-31 | CN¥1.90 Billion | CN¥27.54 Million | 0.014x | -69.23% |
| 2013-12-31 | CN¥1.73 Billion | CN¥81.26 Million | 0.047x | +125.43% |
| 2012-12-31 | CN¥1.58 Billion | CN¥33.09 Million | 0.021x | -63.20% |
| 2011-12-31 | CN¥1.34 Billion | CN¥76.28 Million | 0.057x | -- |